PACIRA BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-42.6M | $-37.9M | $1.9M | $-13.7M | $-63.9M | $-52.3M | $-43.3M | $-27.1M |
| Depreciation & Amortization | $13.8M | $12.9M | $11.5M | $10.0M | $5.7M | $5.6M | $4.3M | $4.1M |
| Depreciation | $13.8M | $12.8M | $11.2M | $9.3M | $3.7M | $3.6M | $2.0M | $1.8M |
| Amortization | $0 | $100.0K | $300.0K | $800.0K | $2.1M | $2.1M | $2.3M | $2.3M |
| Stock-Based Compensation | $31.6M | $31.2M | $33.4M | $24.8M | $11.5M | $4.8M | $2.5M | $23.0K |
| Net Cash from Operating Activities | $17.8M | $33.5M | $28.0M | $26.6M | $-43.8M | $-70.1M | $-31.0M | $-24.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $19.3M | $24.7M | $40.3M | $23.0M | $12.2M | $18.3M | $6.2M | $6.8M |
| Business Acquisitions | $0 | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-223.8M | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | $2.0K |
| Net Cash from Financing Activities | $224.2M | — | — | — | — | — | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-1.5M | $8.7M | $-12.3M | $3.6M | $-56.0M | $-88.4M | $-37.2M | $-31.7M |